tiprankstipranks
Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
US Market
UNCY
Unicycive Therapeutics
RESEARCH TOOLSreports

Unicycive Therapeutics (UNCY) Income Statement

841 Followers

Unicycive Therapeutics Income Statement

Last quarter (Q4 2025), Unicycive Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Unicycive Therapeutics's net income was $-14.67M. See Unicycive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 675.00K$ 951.00K$ 0.00
Gross Profit
$ -572.00K$ 0.00$ 675.00K$ 951.00K$ 0.00
Operating Expenses
$ 28.95M$ 32.12M$ 21.45M$ 19.00M$ 8.98M
Depreciation and Amortization
$ 572.00K$ 428.00K$ 284.00K$ 161.00K$ 13.00K
EBITDA
$ -25.91M$ -36.23M$ -30.18M$ -17.89M$ -9.38M
Operating Income
$ -29.52M$ -32.12M$ -20.77M$ -18.05M$ -8.98M
Other Income/Expenses
$ 2.96M$ -4.61M$ -9.77M$ -6.00K$ -1.04M
Pretax Income
$ -26.55M$ -36.73M$ -30.54M$ -18.06M$ -10.02M
Net Income
$ -26.55M$ -36.73M$ -30.54M$ -18.06M$ -10.02M
Per Share Metrics
Basic EPS
$ -1.67$ -5.60$ -1.28$ -1.20$ -8.60
Diluted EPS
$ -1.67$ -5.60$ -1.28$ -1.20$ -8.60
Weighted Average Shares Outstanding
 158.87M- 2.45M 1.51M 1.17M
Weighted Average Shares Outstanding (Diluted)
 158.87M- 2.45M 1.51M 1.17M
Currency in USD

Unicycive Therapeutics Earnings and Revenue History